Substance use disorders (SUDs) are closely linked to neurochemical imbalances in the brain. Drugs and alcohol disrupt normal neurotransmitter activity, particularly dopamine, serotonin, and glutamate systems. This dysregulation contributes to cravings, withdrawal symptoms, and compulsive substance-seeking behaviors. Chronic use alters brain reward pathways, making natural rewards less satisfying and perpetuating addiction cycles. Addressing these imbalances often requires a combination of pharmacotherapy, such as medications that stabilize neurotransmitter levels, and behavioral interventions like CBT. Understanding the neurochemical underpinnings of SUDs enables clinicians to tailor treatments, improving recovery outcomes and reducing relapse risks.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : PIVOT: Predictive intervention for vaping using resonance modeling of oscillatory, psychological, and trigger dynamics
Aadya, Issaquah High School, United States
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : What to do when a tragedy strikes
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Reward deficiency syndrome solution patient claims ‘dopamine homeostasis’ provided the neurological stability to begin focusing upon healing psychic fracture associated with chronic post-traumatic stress disorder dissociative multiplicity
Elizabeth Dale Gilley, The Elle Foundation, United States